Researchers found a gut-related receptor tied to heart damage from sleep apnea, offering a potential new treatment target.

Studies in mice reveal a new target for potentially treating and preventing life-threatening cardiovascular complications in ...

Drugmaker Eli Lilly presented trial results to medical professionals on Saturday showing its next-generation ​obesity drug retatrutide curbed sleep apnea severity in ‌addition to boosting weight loss ...

New research shows GLP-1 drugs like Ozempic may reduce sleep apnea severity — here's what the latest science says ...

Studies in mice reveal a new target for potentially treating and preventing life-threatening cardiovascular complications in ...

Athens-Limestone Hospital introduces the FDA-approved Genio system to North Alabama, offering innovative nerve stimulation ...

Eli Lilly and its rivals, including Denmark's Novo Nordisk, are in a race to dominate the booming market for obesity and ...

Wearables like the Apple Watch and Oura Smart Ring often have substantial positive impacts on the health and fitness ...

A study found quetiapine reduced obstructive sleep apnea events but tripled attention lapses and impaired driving the next ...

But for millions of people, the hours don't matter, because what's happening during those hours is closer to suffocation than ...

A new sleep apnea pill reduced symptoms by 44 per cent in trials, offering hope for patients struggling with uncomfortable ...

Athens-Limestone Hospital is marking a new milestone in sleep surgery, highlighting expanded access to advanced treatment ...